ChAracterisation of ItaliaN Severe Uncontrolled Asthmatic patieNts Key Features When Receiving Benralizumab

CompletedOBSERVATIONAL
Enrollment

217

Participants

Timeline

Start Date

March 13, 2020

Primary Completion Date

July 15, 2020

Study Completion Date

July 15, 2020

Conditions
Severe Asthma
Interventions
OTHER

No intervention

Patients currently in treatment with benralizumab as per approved indication and clinical practice

Trial Locations (18)

Unknown

Research Site, Acquaviva delle Fonti

Research Site, Bergamo

Research Site, Cassano Murge

Research Site, Catanzaro

Research Site, Florence

Research Site, Foggia

Research Site, Garbagnate Milanese

Research Site, Milan

Research Site, Monserrato

Research Site, Napoli

Research Site, Ostuni

Research Site, Reggio Emilia

Research Site, Roma

Research Site, Rozzano

Research Site, Siena

Research Site, Torino

Research Site, Treviso

Research Site, Verona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY